Skip to main content
Top
Published in: Reactions Weekly 1/2023

01-01-2023 | Cushing's Syndrome | Case report

Multiple drugs

Cushing's syndrome, lack of efficacy, neutropenia following off label use: case report

Published in: Reactions Weekly | Issue 1/2023

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Carrion-Barbera I, et al. Safe and successful treatment of refractory polyarteritis nodosa with tocilizumab in a patient with past hepatitis B virus infection: a case-based review. Clinical Rheumatology 40: 2065-2070, No. 5, May 2021. Available from: URL: http://doi.org/10.1007/s10067-020-05345-4 Carrion-Barbera I, et al. Safe and successful treatment of refractory polyarteritis nodosa with tocilizumab in a patient with past hepatitis B virus infection: a case-based review. Clinical Rheumatology 40: 2065-2070, No. 5, May 2021. Available from: URL: http://​doi.​org/​10.​1007/​s10067-020-05345-4
Metadata
Title
Multiple drugs
Cushing's syndrome, lack of efficacy, neutropenia following off label use: case report
Publication date
01-01-2023
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-31017-9

Other articles of this Issue 1/2023

Reactions Weekly 1/2023 Go to the issue

Case report

Tocilizumab

Case report

Insulin